Kelyniam Global
corporate_fare Company Profile
Kelyniam Global (OTC:KLYG) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for KLYG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 1 rated 8 or above.
Recent high-impact activity:
- Kelyniam Swings to Operating Profit as Nine-Month Revenue Jumps 35%
- Kelyniam Global Reports 84% Revenue Surge, Swings to Q1 Operating Profit
Short Interest & Short Volume
On November 20, 2026, 55.9% of KLYG volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.